[HTML][HTML] Anti-phospholipid antibodies and COVID-19 thrombosis: a co-star, not a supporting actor
FJ Gil-Etayo, S Garcinuño, A Lalueza, R Díaz-Simón… - Biomedicines, 2021 - mdpi.com
Background: COVID-19 clinical features include a hypercoagulable state that resembles the
antiphospholipid syndrome (APS), a disease characterized by thrombosis and presence of …
antiphospholipid syndrome (APS), a disease characterized by thrombosis and presence of …
Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor
FJ Gil-Etayo, S Garcinuño, A Lalueza… - …, 2021 - search.proquest.com
Background: COVID-19 clinical features include a hypercoagulable state that resembles the
antiphospholipid syndrome (APS), a disease characterized by thrombosis and presence of …
antiphospholipid syndrome (APS), a disease characterized by thrombosis and presence of …
Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor.
FJ Gil-Etayo, S Garcinuño, A Lalueza, R Díaz-Simón… - Biomedicines, 2021 - europepmc.org
Background: COVID-19 clinical features include a hypercoagulable state that resembles the
antiphospholipid syndrome (APS), a disease characterized by thrombosis and presence of …
antiphospholipid syndrome (APS), a disease characterized by thrombosis and presence of …
Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor
FJ Gil-Etayo, S Garcinuño, A Lalueza, R Díaz-Simón… - 2021 - agris.fao.org
Background: COVID-19 clinical features include a hypercoagulable state that resembles the
antiphospholipid syndrome (APS), a disease characterized by thrombosis and presence of …
antiphospholipid syndrome (APS), a disease characterized by thrombosis and presence of …
[HTML][HTML] Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor
FJ Gil-Etayo, S Garcinuño, A Lalueza… - …, 2021 - ncbi.nlm.nih.gov
Background: COVID-19 clinical features include a hypercoagulable state that resembles the
antiphospholipid syndrome (APS), a disease characterized by thrombosis and presence of …
antiphospholipid syndrome (APS), a disease characterized by thrombosis and presence of …
Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor.
FJ Gil-Etayo, S Garcinuño, A Lalueza… - …, 2021 - search.ebscohost.com
Background: COVID-19 clinical features include a hypercoagulable state that resembles the
antiphospholipid syndrome (APS), a disease characterized by thrombosis and presence of …
antiphospholipid syndrome (APS), a disease characterized by thrombosis and presence of …
[引用][C] Anti‐phospholipid antibodies and covid‐19 thrombosis: A co‐star, not a supporting actor
FJ Gil‐etayo, S Garcinuño, A Lalueza… - …, 2021 - produccioncientifica.ucm.es
Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor
FJ Gil-Etayo, S Garcinuño, A Lalueza… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Background COVID-19 clinical features include a hypercoagulable state that resembles the
antiphospholipid syndrome (APS), a disease characterized by thrombosis and presence of …
antiphospholipid syndrome (APS), a disease characterized by thrombosis and presence of …